Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 35

Sort by

Sort Order Select

Journal Articles

microRNA-22 and TET-2 Mutation in Myelodysplastic Syndrome Patients Treated with Hypomethylating Agents

Seong Kyu Park, MD, Se Hyung Kim, MD, Sung Hee Lim, MD, Chan Kyu Kim, MD, Jong-Ho Won, MD, Dae-Sik Hong, MD PhD

Blood (2018) 132 (Supplement 1): 5127.

https://doi.org/10.1182/blood-2018-99-117943

Published: 2018

Journal Articles

Clinical Impact of the Immune Reconstitution Status on 100 Day after Allogeneic Stem Cell Transplantation with Fludarabine Based Conditioning

Jin Park, MD, Se Hyung Kim, MD, Sung Hee Lim, MD, Jina Yun, MD, Chan Kyu Kim, MD, Kyoung Ha Kim, Jong-Ho Won, MD, Dae-Sik Hong, MD PhD, Seong Kyu Park, MD

Blood (2017) 130 (Supplement 1): 5486.

https://doi.org/10.1182/blood.V130.Suppl_1.5486.5486

Published: 2017

Journal Articles

A Prospective Registry Study of Peg-G-CSF Prophylaxis for Patients with Diffuse Large B-Cell Lymphoma (CISL 1403)

Blood (2017) 130 (Supplement 1): 2840.

https://doi.org/10.1182/blood.V130.Suppl_1.2840.2840

Published: 2017

Journal Articles

Treatment of Bilateral Synchronous Ocular Adnexa Marginal Zone Lymphoma: Consortium for Improving Survival of Lymphoma (CISL) Study

Sung Yong Oh, Jin Seok Kim, MD PhD, Ji Hyun Lee, MD PhD, Won Seog Kim, MD, Ph. D., Seok Jin Kim, MD PhD, Dok Hyun Yoon, MD PhD, Jung Yong Hong, Won-Sik Lee, MD, Hyo Jung Kim, MD PhD, Jong-Ho Won, MD, Byeong Park, MD, Soon Il Lee, Cheolwon Suh, MD PhD

Blood (2017) 130 (Supplement 1): 5155.

https://doi.org/10.1182/blood.V130.Suppl_1.5155.5155

Published: 2017

Journal Articles

Morphological Subtype According to the FAB Classification Correlates with Molecular Subtype Using Genomic Risk Classification Based on Somatic Mutation Profiles in Normal Karyotype AML

Blood (2017) 130 (Supplement 1): 5075.

https://doi.org/10.1182/blood.V130.Suppl_1.5075.5075

Published: 2017

Journal Articles

Prognostic Factors and Response to the Hypomethylating Agents in Hypocellular Myelodysplastic Syndromes: A Retrospective Study from the Korean Society of Hematology AML/MDS Working Party

Blood (2017) 130 (Supplement 1): 4257.

https://doi.org/10.1182/blood.V130.Suppl_1.4257.4257

Published: 2017

Journal Articles

Replication of New Genomic Classification System in Acute Myeloid Leukemia with Normal Karyotype

Blood (2016) 128 (22): 2876.

https://doi.org/10.1182/blood.V128.22.2876.2876

Published: 2016

Journal Articles

Predictors of General Discomfort, Limitations in Activities of Daily Living, and Intention of a Second Donation in Unrelated Hematopoietic Stem Cell Donation

Mark Lee, Jin Ho Jang, Hyo Jin Min, PhD, Hyung In Jang, Jung Hwa Nah, Chuhl Joo Lyu, MD PhD, Kyou Sup Han, MD PhD, Jong-Ho Won, MD, Young Ho Lee, MD PhD, So Young Chong, MD, Yeung Chul Mun, MD PhD, Won Sik Lee, MD PhD, Seok Jin Kim, Inho Kim, MD PhD

Blood (2016) 128 (22): 3375.

https://doi.org/10.1182/blood.V128.22.3375.3375

Published: 2016

Journal Articles

RUNX1 Mutation in Cytogenetically Normal Acute Myeloid Leukemia : Clinical Implications, Co-Mutation Analysis

Blood (2016) 128 (22): 5253.

https://doi.org/10.1182/blood.V128.22.5253.5253

Published: 2016

Journal Articles

Longitudinal Tracking of MDS Patients Using Next Generation Sequencing Provides a Predictive Measure for Azacitidine Response and AML Progression

Blood (2016) 128 (22): 52.

https://doi.org/10.1182/blood.V128.22.52.52

Published: 2016

Journal Articles

Prevalence of Anemia and Treatment Outcomes after Bariatric Surgery-a Retrospective Korean Study

Kim Kyoung Ha, Lee Min-Young, Han Jo Kim, Se Hyoung Kim, Hyun Jung Kim, Lee Sang-Cheol, Bae Sang Byung, Kim Chan-Kyu, Lee Kyu Taeg, Park Sung Kyu, Jong-Ho Won, MD, Dae Sik Hong, MD, Yong Jin Kim

Blood (2015) 126 (23): 4562.

https://doi.org/10.1182/blood.V126.23.4562.4562

Published: 2015

Journal Articles

Comparable Outcomes with Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Patients with or without Aplastic Anemia in a Prospective Korean PNH Registry

Jun Ho Jang, Jin Seok Kim, MD PhD, Deog-Yeon Jo, MD PhD, Je-Hwan Lee, MD PhD, Chul Won Choi, MD PhD, Hyeoung Joon Kim, MD PhD, Jong-Ho Won, MD PhD, Joo Seop Chung, MD PhD, Hawk Kim, MD PhD, Jae-Hoon Lee, MD PhD, Sang Kyun Sohn, MD PhD, Jeong A Kim, MD PhD, Jong Wook Lee, MD PhD

Blood (2015) 126 (23): 4789.

https://doi.org/10.1182/blood.V126.23.4789.4789

Published: 2015

Journal Articles

A Multi-Center, Non-Randomized Phase 2 Study of Ofatumumab in Combination with ICE-Chemotherapy (O-ICE) in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Tiffany Tang, MBBS, MRCP, Cindy Lim, Miriam Tao, MBBS, MRCP, Richard Quek, MBBS, MRCP, Mohamad Farid, Won Seog Kim, MDPhD, Seok Jin Kim, MD PhD, Seong Hyun Jeong, Jong-Ho Won, MD, Nooraisyah Ismail, Soon Thye Lim, MBBS, MRCP

Blood (2014) 124 (21): 5465.

https://doi.org/10.1182/blood.V124.21.5465.5465

Published: 2014

Journal Articles

Ineffective Corticosteroid Treatment for Hemolysis Management of Paroxysmal Nocturnal Hemoglobinuria

Jong Wook Lee, MD PhD, Jun Ho Jang, MD PhD, Je-Hwan Lee, MD PhD, Deog-Yeon Jo, MD PhD, Jin Seok Kim, Yong Park, MD PhD, Sang Kyun Sohn, MD PhD, Jun Sung Park, MD PhD, Chul Won Choi, MD PhD, Joo Seop Chung, MD PhD, Jae Hoon Lee, MD PhD, Jeong A Kim, MD PhD, Jong-Ho Won, MD PhD

Blood (2014) 124 (21): 5151.

https://doi.org/10.1182/blood.V124.21.5151.5151

Published: 2014

Journal Articles

Side Population of Multiple Myeloma and Multiple Myeloma Stem Cell

Kyoung Ha Kim, Hee-Jeong Cheong, Sook-Ja Kim, Se Hyung Kim, Jina Yoon, Han Jo Kim, Hyun Jung Kim, Sang-Cheol Lee, Sang Byung Bae, Chan-Kyu Kim, Namsu Lee, Kyu Taeg Lee, Sung Kyu Park, Dae Sik Hong, Jong-Ho Won, MD, Hyun Jung Jun, Myung Hee Chang

Blood (2014) 124 (21): 5786.

https://doi.org/10.1182/blood.V124.21.5786.5786

Published: 2014

Journal Articles

Efficacy Of Ruxolitinib In Korean Myelofibrosis Patients and Cases Complicated TB Lymphadenitis During The Treatment

Yeo-Kyeoung Kim, MD, PhD, Se Ryeon Lee, MD, PhD, Yong Park, MD, PhD, Chul Won Choi, MD, PhD, Soo Jeong Kim, MD, PhD, Ho-Young Yhim, MD, PhD, Inho Kim, Doyeun Oh, MD, PhD, Yeung-Chul Mun, Sung-Nam Lim, MD, PhD, Jeong-A Kim, PhD, MD, Myung-Geun Shin, MD, PhD, Jong-Ho Won, MD, PhD

Blood (2013) 122 (21): 1596.

https://doi.org/10.1182/blood.V122.21.1596.1596

Published: 2013

Journal Articles

Weekly Four Times Rituximab Consolidation Following Reduced Cycles Of R-CHOP Induction Chemotherapy In Extremely Elderly Patients With Diffuse Large B Cell Lymphoma

Deok-Hwan Yang, MD, PhD, Won Seog Kim, Young-Rok Do, PhD, Sung Yong Oh, Min Kyoung Kim, Yeung-Chul Mun, Ho-Jin Shin, Jae-Yong Kwak, Hye Jin Kang, Jong-Ho Won, MD, PhD, Jung hye Kwon, Hyo Jung Kim, MD, PhD, Cheolwon Suh, Je-Jung Lee, MD, PhD

Blood (2013) 122 (21): 3031.

https://doi.org/10.1182/blood.V122.21.3031.3031

Published: 2013

Journal Articles

NPM1, IDH1/2 and DNAH11 Gene Mutations Can Improve a Prognostic Stratification of Acute Myeloid Leukemia Patients with Normal Karyotype but Not Harboring FLT3/ITD Mutation.

Yeo-Kyeoung Kim, MD, PhD, Il-Kwon Lee, PhD, Dennis Dong Hwan Kim, MD, PhD, Chul Won Jung, MD, PhD, Jun-Ho Jang, MD, PhD, Hee Je Kim, MD, PhD, Joon Ho Moon, MD, Sang Kyun Sohn, MD, Jong-Ho Won, MD, PhD, Sung-Hyun Kim, Jungwon Huh, MD, PhD, Namshin Kim, PhD, Yun Gyeong Lee, PhD, Sung-Hoon Jung, MD, Je-Jung Lee, MD, PhD, Hyeoung-Joon Kim, MD, PhD

Blood (2012) 120 (21): 2534.

https://doi.org/10.1182/blood.V120.21.2534.2534

Published: 2012

Journal Articles

Whole Exome Sequencing Analysis in AML with Normal Karyotype Not Harboring FLT3/ITD Mutation Reveals Novel Genetic Alterations.

Blood (2012) 120 (21): 2593.

https://doi.org/10.1182/blood.V120.21.2593.2593

Published: 2012

Journal Articles

Prospective Cohort Study with Risk-Adapted Central Nervous System (CNS) Evaluation in Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP: Analysis of Incidence and Risk Factors for Secondary CNS Involvement.

Blood (2012) 120 (21): 2683.

https://doi.org/10.1182/blood.V120.21.2683.2683

Published: 2012

NARROW

microRNA-22 and TET-2 Mutation in Myelodysplastic Syndrome Patients Treated with Hypomethylating Agents

Clinical Impact of the Immune Reconstitution Status on 100 Day after Allogeneic Stem Cell Transplantation with Fludarabine Based Conditioning

A Prospective Registry Study of Peg-G-CSF Prophylaxis for Patients with Diffuse Large B-Cell Lymphoma (CISL 1403)

Treatment of Bilateral Synchronous Ocular Adnexa Marginal Zone Lymphoma: Consortium for Improving Survival of Lymphoma (CISL) Study

Morphological Subtype According to the FAB Classification Correlates with Molecular Subtype Using Genomic Risk Classification Based on Somatic Mutation Profiles in Normal Karyotype AML

Prognostic Factors and Response to the Hypomethylating Agents in Hypocellular Myelodysplastic Syndromes: A Retrospective Study from the Korean Society of Hematology AML/MDS Working Party

Replication of New Genomic Classification System in Acute Myeloid Leukemia with Normal Karyotype

Predictors of General Discomfort, Limitations in Activities of Daily Living, and Intention of a Second Donation in Unrelated Hematopoietic Stem Cell Donation

RUNX1 Mutation in Cytogenetically Normal Acute Myeloid Leukemia : Clinical Implications, Co-Mutation Analysis

Longitudinal Tracking of MDS Patients Using Next Generation Sequencing Provides a Predictive Measure for Azacitidine Response and AML Progression

Prevalence of Anemia and Treatment Outcomes after Bariatric Surgery-a Retrospective Korean Study

Comparable Outcomes with Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Patients with or without Aplastic Anemia in a Prospective Korean PNH Registry

A Multi-Center, Non-Randomized Phase 2 Study of Ofatumumab in Combination with ICE-Chemotherapy (O-ICE) in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Ineffective Corticosteroid Treatment for Hemolysis Management of Paroxysmal Nocturnal Hemoglobinuria

Side Population of Multiple Myeloma and Multiple Myeloma Stem Cell

Efficacy Of Ruxolitinib In Korean Myelofibrosis Patients and Cases Complicated TB Lymphadenitis During The Treatment

Weekly Four Times Rituximab Consolidation Following Reduced Cycles Of R-CHOP Induction Chemotherapy In Extremely Elderly Patients With Diffuse Large B Cell Lymphoma

NPM1, IDH1/2 and DNAH11 Gene Mutations Can Improve a Prognostic Stratification of Acute Myeloid Leukemia Patients with Normal Karyotype but Not Harboring FLT3/ITD Mutation.

Whole Exome Sequencing Analysis in AML with Normal Karyotype Not Harboring FLT3/ITD Mutation Reveals Novel Genetic Alterations.

Prospective Cohort Study with Risk-Adapted Central Nervous System (CNS) Evaluation in Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP: Analysis of Incidence and Risk Factors for Secondary CNS Involvement.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only